|
業務類別
|
-- |
|
業務概覽
|
Grand Pharmaceutical Group Ltd, is an international pharmaceutical company of technological innovation. Its core businesses cover three areas: nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, pharmaceutical technology, and biotechnology. Based on the pharmaceutical and biological industries, the Group focuses on the needs of patients, and technological innovation as the driving force Geographically, it derives a majority of its revenue from the PRC and also has a presence in America; Europe; and Asia other than the PRC, and others. |
| 公司地址
| 99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| https://www.grandpharma.cn |
| 員工數量
| 11987 |
| Dr. Lin Shi |
Director; Deputy President and Chief Pharmaceutical Officer of Grand Pharma (China) Co., Ltd. |
-- |
27/04/2023 |
| Dr. Yan Shao |
Chief Executive Officer and Director |
-- |
27/04/2023 |
| Mr. Zhanqi Niu |
Director; President, Pharmaceutical Management Headquarters of China Grand Enterprises Incorporation |
-- |
27/04/2023 |
|
|
| Dr. Lin Shi |
Director; Deputy President and Chief Pharmaceutical Officer of Grand Pharma (China) Co., Ltd. |
27/04/2023 |
| Dr. Weikun Tang |
Chairman of the Board |
27/04/2023 |
| Mr. Yebi Hu |
Independent Director |
27/04/2023 |
| Dr. Geng Pei |
Independent Director |
27/04/2023 |
| Dr. Yan Shao |
Chief Executive Officer and Director |
27/04/2023 |
| Mr. Zhanqi Niu |
Director; President, Pharmaceutical Management Headquarters of China Grand Enterprises Incorporation |
27/04/2023 |
| Ms. Tosi Wan Winnie So |
Independent Director |
27/04/2023 |
|
|
|
|
